Learned adaptive multiphoton illumination microscopy for large-scale immune response imaging. Read more about Learned adaptive multiphoton illumination microscopy for large-scale immune response imaging.
The transcriptional landscape of Shh medulloblastoma. Read more about The transcriptional landscape of Shh medulloblastoma.
CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer. Read more about CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer.
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions. Read more about Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions.
Joint profiling of DNA and proteins in single cells to dissect genotype-phenotype associations in leukemia. Read more about Joint profiling of DNA and proteins in single cells to dissect genotype-phenotype associations in leukemia.
Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling. Read more about Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling.
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome. Read more about Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome.
KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation. Read more about KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation.
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Read more about A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts. Read more about Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts.
